4,17-Dioxabicyclo[14.1.0]heptadeca-6,14-diene-5,13-dione,2-[[(6-deoxy-2,3-di-O-methyl-b-D-allopyranosyl)oxy]methyl]-2-hydroxy-3,8,10,12-tetramethyl-9-[[3,4,6-trideoxy-3-(dimethylamino)-b-D-xylo-hexopyranosyl]oxy]-,(1R,2S,3R,6E,8S,9S,10S,12R,14E,16S)- (9CI)
| Product Information | |
|---|---|
| Product Number: | AX-HK4X |
| Product Name: | 4,17-Dioxabicyclo[14.1.0]heptadeca-6,14-diene-5,13-dione,2-[[(6-deoxy-2,3-di-O-methyl-b-D-allopyranosyl)oxy]methyl]-2-hydroxy-3,8,10,12-tetramethyl-9-[[3,4,6-trideoxy-3-(dimethylamino)-b-D-xylo-hexopyranosyl]oxy]-,(1R,2S,3R,6E,8S,9S,10S,12R,14E,16S)- (9CI) |
| CAS: | 129046-66-8 |
| MW: | |
| Synonyms: | MycinamicinI, 15-deethyl-14-hydroxy-15-methyl-; 4,17-Dioxabicyclo[14.1.0]heptadecane,mycinamicin I deriv.; Mycinamicin XIII; Mycinamycin XIII |
| EINECS: | |
| Density: | |
| Melting Point: | |
| Boiling Point: | |
| Flash Point: | |
| Solubility: | |
| Risk Codes: | |
| Transport Information:: | |